CVS Stock Overview
CVS Health Corporation provides health services in the United States.
CVS Health Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$101.56|
|52 Week High||US$107.26|
|52 Week Low||US$68.02|
|1 Month Change||0.65%|
|3 Month Change||16.04%|
|1 Year Change||37.02%|
|3 Year Change||55.17%|
|5 Year Change||30.62%|
|Change since IPO||797.77%|
Recent News & Updates
Is CVS Health Corporation (NYSE:CVS) Trading At A 35% Discount?
How far off is CVS Health Corporation ( NYSE:CVS ) from its intrinsic value? Using the most recent financial data...
Is CVS A Dividend Stock To Watch After The Dividend Increase?
After a hiatus designed to reduce debt following the Aetna acquisition, CVS recently raised its dividend payout for the first time since 2017. The firm’s three segments generate synergies, while the PBM and Aetna provide shallow but enduring moats. Investors fear competition from Amazon.
|CVS||US Healthcare||US Market|
Return vs Industry: CVS exceeded the US Healthcare industry which returned 12.8% over the past year.
Return vs Market: CVS exceeded the US Market which returned 6.6% over the past year.
|CVS Average Weekly Movement||3.2%|
|Healthcare Industry Average Movement||7.9%|
|Market Average Movement||6.7%|
|10% most volatile stocks in US Market||15.6%|
|10% least volatile stocks in US Market||2.4%|
Stable Share Price: CVS is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: CVS's weekly volatility (3%) has been stable over the past year.
About the Company
CVS Health Corporation provides health services in the United States. The company’s Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals.
CVS Health Fundamentals Summary
|CVS fundamental statistics|
Is CVS overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|CVS income statement (TTM)|
|Cost of Revenue||US$234.71b|
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
Feb 09, 2022
|Earnings per share (EPS)||5.74|
|Net Profit Margin||2.67%|
How did CVS perform over the long term?See historical performance and comparison
2.2%Current Dividend Yield
Is CVS Health undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: CVS ($101.56) is trading below our estimate of fair value ($159.12)
Significantly Below Fair Value: CVS is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: CVS is good value based on its PE Ratio (17.7x) compared to the US Healthcare industry average (20.3x).
PE vs Market: CVS is poor value based on its PE Ratio (17.7x) compared to the US market (16.7x).
Price to Earnings Growth Ratio
PEG Ratio: CVS is poor value based on its PEG Ratio (3.4x)
Price to Book Ratio
PB vs Industry: CVS is good value based on its PB Ratio (1.8x) compared to the US Healthcare industry average (2.6x).
How is CVS Health forecast to perform in the next 1 to 3 years based on estimates from 20 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CVS's forecast earnings growth (5.2% per year) is above the savings rate (2%).
Earnings vs Market: CVS's earnings (5.2% per year) are forecast to grow slower than the US market (13.1% per year).
High Growth Earnings: CVS's earnings are forecast to grow, but not significantly.
Revenue vs Market: CVS's revenue (4.3% per year) is forecast to grow slower than the US market (9.2% per year).
High Growth Revenue: CVS's revenue (4.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CVS's Return on Equity is forecast to be low in 3 years time (14%).
How has CVS Health performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CVS has high quality earnings.
Growing Profit Margin: CVS's current net profit margins (2.7%) are lower than last year (3%).
Past Earnings Growth Analysis
Earnings Trend: CVS's earnings have grown by 11.5% per year over the past 5 years.
Accelerating Growth: CVS's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: CVS had negative earnings growth (-4.6%) over the past year, making it difficult to compare to the Healthcare industry average (32.5%).
Return on Equity
High ROE: CVS's Return on Equity (10.2%) is considered low.
How is CVS Health's financial position?
Financial Position Analysis
Short Term Liabilities: CVS's short term assets ($60.8B) do not cover its short term liabilities ($64.7B).
Long Term Liabilities: CVS's short term assets ($60.8B) do not cover its long term liabilities ($95.6B).
Debt to Equity History and Analysis
Debt Level: CVS's net debt to equity ratio (59.4%) is considered high.
Reducing Debt: CVS's debt to equity ratio has increased from 74.4% to 76.6% over the past 5 years.
Debt Coverage: CVS's debt is well covered by operating cash flow (31.2%).
Interest Coverage: CVS's interest payments on its debt are well covered by EBIT (8.9x coverage).
What is CVS Health current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: CVS's dividend (2.17%) is higher than the bottom 25% of dividend payers in the US market (1.36%).
High Dividend: CVS's dividend (2.17%) is low compared to the top 25% of dividend payers in the US market (3.55%).
Stability and Growth of Payments
Stable Dividend: CVS's dividends per share have been stable in the past 10 years.
Growing Dividend: CVS's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (34.7%), CVS's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: CVS's dividends in 3 years are forecast to be well covered by earnings (25% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Karen Lynch (58 yo)
Ms. Karen Sue Lynch serves as Chief Executive Officer, President and Director at CVS Health Corporation since February 01, 2021. She has extensive experience in the health care industry. She was Executive...
CEO Compensation Analysis
Compensation vs Market: Karen's total compensation ($USD11.31M) is about average for companies of similar size in the US market ($USD11.42M).
Compensation vs Earnings: Insufficient data to compare Karen's compensation with company performance.
Experienced Management: CVS's management team is considered experienced (2.1 years average tenure).
Experienced Board: CVS's board of directors are considered experienced (8.6 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
CVS Health Corporation's employee growth, exchange listings and data sources
- Name: CVS Health Corporation
- Ticker: CVS
- Exchange: NYSE
- Founded: 1963
- Industry: Health Care Services
- Sector: Healthcare
- Implied Market Cap: US$134.161b
- Shares outstanding: 1.32b
- Website: https://www.cvshealth.com
Number of Employees
- CVS Health Corporation
- One CVS Drive
- Rhode Island
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/01/21 23:34|
|End of Day Share Price||2022/01/21 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.